share_log

Analysts Are Updating Their Wanhua Chemical Group Co., Ltd. (SHSE:600309) Estimates After Its Yearly Results

Analysts Are Updating Their Wanhua Chemical Group Co., Ltd. (SHSE:600309) Estimates After Its Yearly Results

分析師正在公佈年度業績後更新其萬華化學集團有限公司(SHSE: 600309)的估計
Simply Wall St ·  03/20 19:03

Last week saw the newest yearly earnings release from Wanhua Chemical Group Co., Ltd. (SHSE:600309), an important milestone in the company's journey to build a stronger business. Revenues of CN¥175b were in line with forecasts, although statutory earnings per share (EPS) came in below expectations at CN¥5.36, missing estimates by 3.5%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

上週,萬華化學集團有限公司(SHSE: 600309)發佈了最新的年度業績,這是公司建立更強大業務過程中的一個重要里程碑。儘管法定每股收益(EPS)低於預期,爲5.36元人民幣,比預期低3.5%,但收入爲1750億元人民幣,與預期一致。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。考慮到這一點,我們收集了最新的法定預測,以了解分析師對明年的預期。

earnings-and-revenue-growth
SHSE:600309 Earnings and Revenue Growth March 20th 2024
SHSE: 600309 2024 年 3 月 20 日收益和收入增長

Taking into account the latest results, the current consensus from Wanhua Chemical Group's 21 analysts is for revenues of CN¥199.7b in 2024. This would reflect a decent 14% increase on its revenue over the past 12 months. Per-share earnings are expected to bounce 20% to CN¥6.45. In the lead-up to this report, the analysts had been modelling revenues of CN¥199.5b and earnings per share (EPS) of CN¥6.65 in 2024. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a small dip in their earnings per share forecasts.

考慮到最新業績,萬華化學集團的21位分析師目前的共識是,2024年的收入爲1997億元人民幣。這將反映其收入在過去12個月中大幅增長了14%。每股收益預計將反彈20%,至6.45元人民幣。在本報告發布之前,分析師一直在模擬2024年的收入爲199.5億元人民幣,每股收益(EPS)爲6.65元人民幣。因此,在最近的業績公佈之後,整體情緒似乎略有下降——收入估計沒有重大變化,但分析師的每股收益預測確實略有下降。

It might be a surprise to learn that the consensus price target was broadly unchanged at CN¥108, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Wanhua Chemical Group, with the most bullish analyst valuing it at CN¥125 and the most bearish at CN¥95.00 per share. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

得知共識目標股價基本保持不變,爲108元人民幣,這可能會令人驚訝,分析師明確表示,預期的收益下降預計不會對估值產生太大影響。研究分析師的估計範圍,評估異常值與平均值的差異程度也可能很有啓發性。對萬華化學集團的看法有所不同,最看漲的分析師將其估值爲125元人民幣,最看跌的爲每股95.00元人民幣。儘管如此,由於估計範圍如此之窄,這表明分析師對他們認爲該公司的價值有了很好的了解。

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Wanhua Chemical Group's revenue growth is expected to slow, with the forecast 14% annualised growth rate until the end of 2024 being well below the historical 24% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 18% per year. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Wanhua Chemical Group.

了解這些預測的更多背景信息的一種方法是研究它們與過去的業績相比如何,以及同一行業中其他公司的表現。我們要強調的是,萬華化學集團的收入增長預計將放緩,預計到2024年底的年化增長率爲14%,遠低於過去五年24%的歷史年增長率。相比之下,該行業中其他有分析師報道的公司的收入預計將以每年18%的速度增長。因此,很明顯,儘管收入增長預計將放緩,但整個行業的增長速度預計也將超過萬華化學集團。

The Bottom Line

底線

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Wanhua Chemical Group. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at CN¥108, with the latest estimates not enough to have an impact on their price targets.

最大的擔憂是,分析師下調了每股收益預期,這表明萬華化學集團可能會面臨業務不利因素。從好的方面來看,收入估計沒有重大變化;儘管預測表明它們的表現將比整個行業差。共識目標股價穩定在108元人民幣,最新估計不足以對其目標股價產生影響。

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Wanhua Chemical Group going out to 2026, and you can see them free on our platform here..

考慮到這一點,我們仍然認爲該業務的長期發展軌跡對於投資者來說更爲重要。在Simply Wall St,我們有分析師對萬華化學集團到2026年的全方位估計,你可以在我們的平台上免費看到這些估計。

Plus, you should also learn about the 3 warning signs we've spotted with Wanhua Chemical Group (including 1 which is a bit concerning) .

另外,您還應該了解我們在萬華化學集團發現的3個警告信號(其中一個有點令人擔憂)。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論